Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab

Leukemia and Lymphoma

Volumn 46, Issue 6, 2005, Pages 909-914

  Robak, Ewa ^a   Biernat, Wojciech ^a   Krykowski, Euzebiusz ^a   Jeziorski, Arkadiusz ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

B CLL; Cladribine; Merkel cell carcinoma; Purine nucleoside analogs; Rituximab; Treatment

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; B CELL LEUKEMIA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; CHEEK; CHRONIC LYMPHATIC LEUKEMIA; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; MERKEL CELL TUMOR; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, MERKEL CELL; CLADRIBINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHATIC METASTASIS; MIDDLE AGED; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 21844459478     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500057759     Document Type: Article

References (39)

1. Linjawi A, Janison WB, Meterissian S. Merkel cell carcinoma: important aspect of diagnosis and management. Am Surg 2001;67:943-947.
2. Lehrer MS, Hershock D, Ming ME. Merkel cell carcinoma. Curr Treat Options Oncol 2004;5:195-198.
3. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588-598.
4. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999;8:53-158.
5. Shack RB, Barton RM, DeLozier J, Rees RS, Lynch JB. Is aggressive surgical management justified in the treatment of Merkel cell carcinoma? Plast Reconstr Surg 1994;94:970-975.
6. Tennvall J, Biocrklund A, Johansson I, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease: a clinicopathological study of 17 patients. Eur J Surg Oncol 1989;15:1-9.
7. Yiengpruksavan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.
8. Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology 2004;9:387-400.
9. Agnew KL, Ruchlemer R, Catovsky D, Matutes E, Bunker CB. Cutaneous finding in chronic lymphocytic leukemia. Br J Dermatol 2004;150:1129-1135.
10. Ziprin P, Smith S, Salerno G, Rosin RD. Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukemia. Br J Dermatol 2000;42:525-528.
11. Quaglino D, Di Leonardo G, Lalli G et al. Association between chronic lymphocytic leukemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkel cell) carcinoma. Eur Rev Med Pharm Sci 1997;1:11-16.
12. Safadi R, Pappo O, Okon E, Sviri S, Eldor A. Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leuk Lymphoma 1996;20:509-511.
13. Warakaulle DR, Rytina E, Burrows NP. Merkel cell tumour associated with chronic lymphocytic leukaemia. Br J Dermatol 2001;144:216-217.
14. Vlad R, Woodlock TJ. Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review. Am J Clin Oncol 2003;26:531-534.
15. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
16. Robak T, Błoński JZ, Kasznicki M et al. Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. Hematol J 2002;3:244-250.
17. Cheson BD, Bennett JM, Grever M et al. National Cancer Institute Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
18. Robak T, Smolewski P, Urbańska-Ryś H, Góra-Tybor J, Błoński JZ, Kasznicki M. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. Leuk Lymphoma 2004;45:937-944.
19. Chan JK, Suster S, Wenig BM, Tsang WY, Chab JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-234.
20. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas. Mod Pathol 1995;8:384-388.
21. Schmidt U, Muller U, Metz KA, Leder LD. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am J Dermatopathol 1998;20:346-351.
22. Banerjee SS, Agbamu DA, Eyden BP, Harris M. Clinicopathological characteristics of peripheral primitive neuroectodermal tumour of the skin and subcutaneous tissue. Histopathology 1997;31:355-366.
23. Nicholson SA, McDermott MB, Swanson PE, Wick MR. CD99 and cytokeratin 20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 2000;8:37-41.
24. Brady MS. Current management of patients with Merkel cell carcinoma. Dermatol Surg 2004;30:321-325.
25. Linjawi A, Jamison WB, Metrissian S. Merkel cell carcinoma: important aspects of diagnosis and management. Am Surg 2001;67:943-947.
26. Tennvall J, Biorklund A, Johansson L, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients. Eur J Surg Oncol 1989;15:1-9.
27. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.
28. An KP, Ratner D. Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol 2001;45:309-312.
29. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315-323.
30. Catlett JP, Todd WM, Carr ME Jr. Merkel cell tumor in an HIV-positive patient. Va Med Q 1992;119:256-258.
31. Miller J, Huhn K, Goldman G, Dzubow L. Merkel cell carcinoma in a stem cell transplant patient. Dermatol Surg 1998;24:913-914.
32. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999;68:1717-1721.
33. Bartik MM, Welker D, Kay NE. Impairments in immune cell function in B-cell chronic lymphocytic leukemia. Semin Oncol 1998;25:27-33.
34. Seymour JF, Kurzrock R, Freireich EJ, Estey EH. 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 1994;83:2906-2911.
35. Cohen Y, Amir G, Polliack A. Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma. Eur J Hematol 2002;8:117-119.
36. Ott MJ, Tanabe KK, Gadd MA et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999;139:388-392.
37. Gillenvater AM, Hessel AC, Morrison WH et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149-154.
38. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of post operative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:325-331.
39. Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherpy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005;27:208-216.